click below
click below
Normal Size Small Size show me how
P1, top 200, grp 1
Top 200 - Group 1
Brand | Generic | Class | Indication | Dose Form | Route | Adult Dosing | Pediatric Dosing | MOA |
---|---|---|---|---|---|---|---|---|
Lopressor | Metoprolol Tartrate | Beta Blocker | HTN, MI | Tablets: 25, 50, 100mg IV: 5mg/5ml | Oral, IV | HTN: IR: 100-450mg QD or divided MI: Early: inject 3 bolus of 5mg in 2 min intervals >15mins: 25-50mg PO Q6’ x48 hr Late: 100mg BID x3 mos | N/A | Blocks beta receptors, primarily affecting CV system (decreases heart rate, contractility, and BP) and lungs (promotes bronchospasm) |
Toprol XL | Metoprolol Succinate | Beta Blocker | HTN, Angina Pectoris, HF | Tablets: 25, 50, 100, 200mg | Oral | HTN: 25-200mg QD; 400mg max | 6-16 YO: 50-200mg QD | Blocks beta receptors, primarily affecting CV system (decreases heart rate, contractility, and BP) and lungs (promotes bronchospasm) |
Lotensin | Benazepril | Ace Inhibitor | HTN | Tablets: 5, 10, 20, 40mg | Oral | 20-40mg QD-BID; max 80mg/day | >6 YO: 0.1-0.6mg/kg QD; max 40mg/day | Stops angiotensin converting enzyme to reduce BP |
Prinivil; Zestril | Lisinopril | Ace Inhibitor | HTN, HF, MI | Tablets: 2.5, 5, 10, 20, 30, 40mg | Oral | HTN: 20-40mg QD; max 80mg/day HF: 5-20mg QD (Prinivil) or 5-40mg QD (Zestril) Acute MI: 10mg QD | >6 YO: 0.07mg/kg QD; max 5mg/day | Stops angiotensin converting enzyme to reduce BP |
Vasotec | Enalapril | Ace Inhibitor | HTN, HF, Asymptomatic left ventricular dysfunction | Tablets: 2.5, 5, 10, 20mg IV: 1.25mg/ml | Oral, IV | HTN: 5-40mg QD or divided IV: 1.25mg Q6’ over 5 min period HF: 2.5-20mg BID ALVD: 2.5mg BID | 1 mo-16 YO: 0.08mg/kg QD; max 5mg/day | Stops angiotensin converting enzyme to reduce BP |
Cardizem; Cardizem CD; Cardizem LA; Cartia XT; Dilt XR; Matzim LA; Taztia XT; Tiazac | Diltiazem | Calcium Channel Blocker | HTN, Angina, Paroxysmal Supraventricular Tachycardia (PSVT) | SR Caps (BID): 60, 90, 120mg ER Caps (QD): 120, 180, 240, 300, 360, 420mg IR Tabs: 30, 60, 90, 120mg ER Tabs (Cardizem LA): 120, 180, 240, 300, 360, 420mg IV Soln: 5mg/ml | Oral, IV | HTN: ER Caps: 120-490mg QD ER Tabs: 120-540mg QD Angina: ER Caps: 120-480mg QD ER Tabs: 180mg BID PSVT: 5-10mg/hr; increase in 5mg/hr increments up to 15mg/hr maintained for up to 24 hrs | N/A | Block calcium channels to control the heart rate/decrease BP |
Calan; Calan SR; Verelan; Verelan PM | Verapamil SR | Calcium Channel Blocker | HTN, Angina, PSVT | Tablets | Oral | Calan: 40-120mg 3-4 times/day Isoptin: 120-240mg QD-BID (400mg max) | N/A | Block calcium channels to control the heart rate/decrease BP |
Norvasc | Amlodipine | Calcium Channel Blocker | Prophylaxis, Stable Angina, Variant Angina | Tablets: 2.5, 5, 10mg | Oral | 5-10mg QD | 6-17 YO: 2.5-5mg QD | Block calcium channels to control the heart rate/decrease BP |
Imdur; Isordil; Titradose; Dilatrate SR; IsoDitrate ER | Isosorbide Mononitrate; Isosorbide Dinitrate | Nitrate | HTN, Angina | Tablet | Oral | 20-40mg QD | N/A | Organic nitrate that relaxes vascular smooth muscle resulting in dilation of peripheral arteries & veins |
Digitek; Lanoxin; Digox | Digoxin | Cardiac Glycoside | HF, Atrial Fibrillation | Tablet, IV Soln | Oral, IV | AF: initial: 25mg IV/orally Q2’ (max 1.5mg) Maintenance: 0.125-0.375mg IV/oral HF: 2.4-3.6 mcg/kg IV/IM | HF: 1.9-3.1 mcg/kg IV/IM BID | Inhibits Na+/K+ ATPase, which increases intracellular Na+ concentration leading to increased intracellular Ca2+ concentration |
Humira | Adalimumab | Tumor Necrosis Factor Inhibitor (Monoclonal Antibodies) (Antirheumatic) | Crohn’s Disease, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis | Injection Soln. | SubQ | 40mg every other week Ulcerative Colitis: 160mg subQ on day 1, followed by 80mg subQ 2 weeks later | 4 YO: 15-<30kg: 20mg every other week >30kg: 40mg every other week | Binds and inactivates tumor necrosis factor (TNF) suppressing inflammatory and immune response |
Remicade | Infliximab | Immunological Agent | Crohn’s Disease, Psoriasis, Rheumatoid Arthritis | Injection Soln. | IV | 5mg/kg IV over at least 2 hrs given at week 0, 2, and 6, then every 6 weeks thereafter | 6 YO+: 5mg/kg IV over at least 2 hrs given at week 0, 2, and 6 followed by maintenance therapy | IgG that binds to TNF-alpha and neutralizes biological activity |
Enbrel | Etanercept | Immune Suppressant | Rheumatoid Arthritis, Juvenile Arthritis | Injection Soln. | SubQ | 25-100mg subQ every week (can be divided, but doses need not be 72-96 hrs apart) | 2 YO+: 0.8mg/kg subQ once a week (50mg/week max) | Binds and inactivates TNF suppressing inflammatory and immune response |
Avapro | Irbesartan | ARB | HTN, Diabetic Nephropathy, Proteinuria | Tablets: 75, 150, 300 mg | Oral | HTN: 150-300mg QD (75mg for volume depleted pts) Nephropathy w/T2DM: 300mg QD | N/A | Blocks binding site of angiotensin II to AT1 receptor producing a decrease in BP |
Cozaar | Losartan | ARB | HTN, Diabetic Nephropathy | Tablets: 25, 50, 100mg | Oral | Initial dose for both = 50mg HTN: 25-100mg QD-BID Nephropathy w/T2DM & HTN: 100mg QD | >6 YO: 0.7mg/kg QD 50mg max | Blocks binding site of angiotensin II to AT1 receptor producing a decrease in BP |
Benicar | Olmesartan | ARB | HTN | Tablets: 5, 20, 40mg | Oral | 20-40mg QD | 6-17 YO: 10-20mg QD if <35kg; 20-40mg if >35kg | Blocks binding site of angiotensin II to AT1 receptor producing a decrease in BP |
Diovan | Valsartan | ARB | HTN, Heart Failure, Myocardial Infarction (MI) | Tablets: 40, 80, 160, 320mg | Oral | HTN: 80-320mg QD HF: 40mg BID 80-160mg = 320mg max MI: 160mg BID | 6-16 YO: initial: 1.3mg/kg QD (max = 40mg/day) | Blocks binding site of angiotensin II to AT1 receptor producing a decrease in BP |
Bystolic | Nebivolol | Beta Blocker | HTN | Tablets: 2.5, 5, 10, 20mg | Oral | Initial: 5mg QD leading to 40mg QD | N/A | Blocks beta-1 receptors, primarily affecting heart (slows rate), vascular system (decreases BP), and, to lesser extent, lungs (reduces function) |
Tenormin | Atenolol | Beta Blocker | HTN, MI, Angina Pectoris | Tablets: 25, 50, 100mg IV: 0.5mg/ml | Oral, IV | 25-100mg QD or 50mg BID | N/A | Blocks beta-1 receptors, primarily affecting heart (slows rate), vascular system (decreases BP), and, to lesser extent, lungs (reduces function) |
Coreg; Coreg CR | Carvedilol | Beta Blocker | HTN, MI, HF | IR Tablets: 3.125, 6.25, 12.5, 25mg CR Capsules: 10, 20, 40, 80mg | Oral | IR: 3.125-12.5mg BID CR: 10-80mg QD | N/A | Blocks alpha-1 receptors & nonselective beta receptors to decrease BP |